Application and mechanism of anticancer peptides in organoid models of intrahepatic cholangiocarcinoma
Abstract The clinical manifestations of intrahepatic cholangiocarcinoma (ICC) are non-specific, and few patients qualify for surgical resection at diagnosis, thus limiting treatment options. Anticancer peptides (ACPs) exhibit potent tumour inhibition, minimal side effects, easy modification, and low...
Saved in:
| Main Authors: | Xuekai Hu, Yue Zhang, Yanchen Li, Qiuxia Zheng, Haixia Zhao, Yun Zhang, Jingman Ni, Jia Yao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-06127-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cystatin B Promotes the Proliferation, Migration, and Invasion of Intrahepatic Cholangiocarcinoma
by: Dai Zhang, et al.
Published: (2025-01-01) -
A combined radiomics and clinical model for preoperative differentiation of intrahepatic cholangiocarcinoma and intrahepatic bile duct stones with cholangitis: a machine learning approach
by: Hongwei Qian, et al.
Published: (2025-03-01) -
Intrahepatic cholangiocarcinoma with a liver abscess due to hepatic actinomycosis
by: Tomoya Masuda, et al.
Published: (2023-03-01) -
Current principles for the surgical treatment of intrahepatic cholangiocarcinoma
by: Catalin Savin, et al.
Published: (2024-10-01) -
Percutaneous Radio-frequency Assisted Liver Partition with Portal vein embolization in Staged liver resection (PRALPPS) in patients with perihilar and intrahepatic cholangiocarcinoma: evaluation of short-term results
by: O. V. Melekhina, et al.
Published: (2019-04-01)